Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 95.48
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Chemcrux Enterprises Ltd. engages in the manufacture of intermediates for bulk drugs, dyes, electro-plating, pharmaceuticals, and pigments. It specializes in oxidation, nitration, acetylation, and chlorosulfonation chemistry. The company was founded by Girish Champaklal Shah and Sanjaybhai Yashwantrao Marathe on April 01, 1996 and is headquartered in Ankleshwar, India.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.
Data is available to registered users only
Buy
Sell